Ark Invest

ARK Investment Management LLC (ARK Invest) specializes in thematic investing with a clear focus on disruptive innovation. Our goal is to uncover themes that boost productivity and generate wealth. We delve into research and invest in technology-driven innovations that span various economic sectors and transform how we live and work. Some of our current themes include Industrial Innovation, Next Generation Internet, FinTech, and the Genomic Revolution. We believe that innovation is crucial for growth and ultimately prevails in the equity market. ARK has a dedicated research team that helps us spot long-term trends before they become apparent in the market. Our distinctive research approach utilizes a variety of data sources—both internal and external—resulting in unique insights and analysis.

Trade/B2B

English

Corporate/Government Newsroom

Outlet metrics

Domain Authority

Ranking

Global

#225248

United States

#140897

Finance/Investing

#1341

Traffic sources

Monthly visitors

Articles

April 4, 2025 - In The Know With Cathie Wood

3 weeks ago | ark-invest.com | Catherine Wood

On episode LXVI of "In The Know" (April 4, 2025), ARK CEO/CIO Cathie Wood emphasizes the importance of understanding the political backdrop, particularly regarding tariffs and their implications for the economy. She also discusses the current macroeconomic landscape, focusing on the impact of fiscal and monetary policies, the ongoing rolling recession, and the potential for innovation to drive future growth.
#456: Waymo’s Safety Improves While Tesla Has The Data Advantage Ahead Of Its Robotaxi Launch In June, & More

1 month ago | ark-invest.com | Tasha Keeney |Daniel C. Maguire |Frank Downing |Brett Winton

Last week, Google announced the sixth-largest US tech merger and acquisition (M&A) transaction in history—and the largest in its own corporate history—when it acquired Wiz, a private cybersecurity company, for $32 billion in cash.13 The transaction follows a severely restrained M&A environment driven largely by restrictions imposed by the Federal Trade Commission (FTC).
Revolutionizing Cancer Treatment: Umoja’s Vision For In Vivo Therapies

1 month ago | ark-invest.com | Charles Roberts |Brett Winton

In this episode of For Your Innovation, the ARK team is joined by Umoja’s CEO, Dr. Andy Scharenberg, and CFO, Britton Russell, to discuss their journey, vision, and the innovative science reshaping cancer treatment. Dr. Scharenberg explains how Umoja’s in vivo gene delivery platform, VivoVec, represents a third-generation leap in CAR T-cell therapies—offering the potential to make cutting-edge treatments more scalable, accessible, and cost-effective.
#455: Apple Is Delaying Apple Intelligence, & More

1 month ago | ark-invest.com | Nemo focuses |Brett Winton |Nemo Marjanovic |Tasha Keeney

Apple has delayed the release of some of its most widely touted Apple Intelligence features until 2026 or later.1 Though the delay may be a surprise to seasoned Apple observers,2 disruptive technologies are challenging for incumbents—now including Apple—to incorporate.3 The characteristics that make AI interesting may not be consistent with Apple’s buttoned-up, optimized ecosystem.
March 7, 2025 - In The Know With Cathie Wood

1 month ago | ark-invest.com | Catherine Wood

Intro Economic Overview Federal Budget Deficit Or Surplus Percent Of Nominal GDP Sources of federal revenues since 1790 M2 Money Supply vs CPI Inflation Velocity Of M2 Money Supply Velocity Of M2 Money Supply YOY Percent Change Consumer Sentiment Index University of Michigan Expected Inflation Rate 1 Year Ahead University of Michigan Expected Inflation Rate 5-10 Years Ahead University of Michigan Average Weekly Hours Worked Existing Home Sales SAAR US Net Income Noncorporate Divided By...
AI-Native Enterprises: The Future Of Work With Box CEO Aaron Levie

1 month ago | ark-invest.com | Frank Downing |Brett Winton

Welcome to FYI - For Your Innovation. In this episode, Brett Winton, ARK’s Chief Futurist, and Frank Downing, Director of Research, Next Generation Internet, sit down with Aaron Levie, CEO and co-founder of Box, to discuss the transformative impact of artificial intelligence on enterprise software. With nearly 20 years of experience leading a cloud-native company, Aaron shares his perspective on how AI is fundamentally reshaping productivity, software business models, and competitive dynamics.
How Tempus Is Using AI To Transform Diagnostics With Eric Lefkofsky

1 month ago | ark-invest.com | Brett Winton

Welcome to FYI - For Your Innovation. In this episode, Eric Lefkofsky, CEO of Tempus, shares his journey from leading tech companies like Groupon to pioneering innovation in healthcare through AI. Lefkofsky explains how Tempus integrates advanced technology into medical diagnostics, making healthcare more precise and data-driven. He discusses the challenges of the U.S. healthcare system, the power of AI in personalized medicine, and the critical role of bridging gaps between technology and biology.
Risks In Bitcoin: Supply Chain And Hardware Centralization

2 months ago | ark-invest.com | Catherine Wood

Since inception, ARK has researched and published thoughts on the cryptocurrency ecosystem within Big Ideas and through articles, whitepapers, monthly Bitcoin reports and podcasts. Now, in coordination with Bitcoin Park, ARK is pleased to host a monthly conversation with leaders in the Bitcoin space, to discuss everything happening in the rapidly-changing and still nascent Bitcoin ecosystem.
February 7, 2025 - In The Know with Cathie Wood

2 months ago | ark-invest.com | Catherine Wood

Intro Federal Budget Deficit Or Surplus Percent of Nominal GDP Sources of federal revenues since 1790 Real GDP Vs. Productivity USD Index (DXY) Yield Curve 10-Year Treasury Yield Minus 2-Year Yield Curve 10-Year Treasury Yield Minus 2-Year M2 Money Supply vs CPI Inflation New Tenant Rent Leads Rents Lower Velocity Of M2 Money Supply Velocity Of M2 Money Supply YOY Percent Change Consumer Sentiment Index University of Michigan Expected Inflation Rate 1 Year Ahead University of Michigan...
Replacing Animal Testing: Organoids And AI With Thomas Hartung

Jan 24, 2025 | ark-invest.com | Nemo focuses |Nemo Marjanovic |Brett Winton

In this episode of FYI, Brett Winton and Nemo Marjanovic sit down with Professor Thomas Hartung, MD-PhD, a leading expert in biomedical innovation at Johns Hopkins Bloomberg School of Public Health. They explore how human organoids—3D organ proxies—are revolutionizing drug discovery and toxicology testing by reducing reliance on animal models.